MCCS publishes ‘broader’ cannabis prescription guidelines

The Medical Cannabis Clinicians’ Society (MCCS) and the All-Party Parliamentary Group (APPG) for Medical Cannabis under Prescription issued new guidance last week identifying conditions for which there are “conclusive or substantial”, “moderate”, and “limited” evidence of efficacy of medical cannabis treatment, as well as those for which it says there is “no conclusive evidence”. Mike […]

Continue Reading

New study: Cannabis oil ‘significantly improves the symptoms of Crohn’s disease and the quality of life of sufferers’

Cannabis oil has been shown to “significantly improve the symptoms of Crohn’s disease and the quality of life of sufferers”, according to a new study, despite having “no effect on gut inflammation”. That inflammation was uneffected may have been down to the dosage – 15% CBD and THC 4% – not  being strong enough. As […]

Continue Reading

UKCSC chairman Greg de Hoedt published in the British Medical Journal

UKCSC chairman Greg de Hoedt has been published in the British Medical Journal. The article, ‘Patients like me manage lifelong illness with cannabis. For us, the UK is a hostile environment’ was released on 27 July and will be available in print on 4 August. In it Greg explains why his life-threatening Crohn’s disease was […]

Continue Reading